| | | |

Psychiatric Medication for Children and Adolescents: What South Shore Parents Need to Know Before Saying Yes

Bylindenspitalpmhnp

“Should my child take psychiatric medication?”

It is one of the most charged questions in pediatric mental health — and one that deserves a thoughtful, evidence-based answer rather than reflexive reassurance or reflexive fear.

At BRN Psychiatry, Linden Spital, PMHNP works with families across Quincy, Weymouth, Braintree, Hingham, Plymouth, Scituate, Marshfield, Norwell, Duxbury, Milton, and Randolph to make medication decisions that are clinically sound, individually tailored, and fully collaborative. This post is designed to give South Shore parents the framework they need to have that conversation — with their child’s providers, and with their child.

Schedule Appointment with BRN Psychiatry

The Purpose of Psychiatric Medication in Children and Adolescents

Psychiatric medications do not change who a child is. They do not suppress personality, create dependence in the traditional sense, or substitute for therapy. What they can do — when indicated, appropriately chosen, and properly managed — is reduce the neurobiological burden of psychiatric illness enough that a child can access their own capacity for growth, learning, and development.

Think of it this way: a child with severe anxiety cannot benefit from exposure therapy if their anxiety is so overwhelming that they cannot engage. A teenager with untreated depression cannot respond to cognitive interventions if they cannot access their own thoughts. In these cases, medication is not a shortcut — it is what makes treatment possible.

The Decision Framework: How BRN Psychiatry Approaches Medication Decisions

At BRN Psychiatry, Linden Spital, PMHNP approaches medication decisions through a structured clinical process:

1. Accurate Diagnosis First

Medication selection depends entirely on accurate diagnosis. The wrong medication for the wrong diagnosis does not produce improvement — it produces side effects, frustration, and the erroneous conclusion that “medication doesn’t work for my child.” A comprehensive psychiatric evaluation is always the starting point. Read about what a BRN Psychiatry evaluation involves →

2. Severity and Functional Impairment

Medication is typically considered when:

  • Symptoms are causing significant impairment in at least one domain (school, home, peer relationships, self-care)
  • The condition is moderate to severe in intensity
  • Psychotherapy alone has not been sufficient, or when the severity is such that the child cannot benefit from therapy without pharmacological support

3. Risk-Benefit Analysis, Individualized

Every medication decision involves a risk-benefit calculation that is specific to each child. Relevant factors include age, weight, medical history, other medications, co-occurring conditions, and family history of medication response. The risk of medication must always be weighed against the risk of untreated illness — which is not zero.

4. Informed Consent and Family Partnership

Families are full partners in medication decisions at BRN Psychiatry. Linden Spital, PMHNP provides plain-language explanations of how each medication works, what to expect, what to watch for, and how decisions will be made over time. Older adolescents are included in the informed consent process directly.

Medications Commonly Used in Child and Adolescent Psychiatry

Stimulants (for ADHD)

Methylphenidate (Ritalin, Concerta, Vyvanse, Focalin) and amphetamine formulations (Adderall, Vyvanse, Dexedrine) are the most commonly prescribed psychiatric medications in pediatrics and have the most robust evidence base in all of pediatric psychopharmacology. Decades of research across hundreds of trials support their safety and efficacy.

Common concerns addressed:

  • “Will stimulants stunt my child’s growth?” — Stimulants produce a modest, typically temporary effect on growth velocity. This is monitored closely and is manageable in most cases.
  • “Will my child become addicted?” — Properly used stimulants for ADHD are associated with reduced rates of substance use disorders, not increased.
  • “Will it change my child’s personality?” — The goal of correct dose titration is to reduce ADHD symptoms while preserving — not suppressing — the child’s personality. Blunted affect or emotional “flatness” indicates a dose adjustment is needed.

Non-stimulant alternatives including atomoxetine, guanfacine ER (Intuniv), and clonidine ER (Kapvay) are effective options for children who don’t respond to or can’t tolerate stimulants.

SSRIs (for Anxiety, Depression, and OCD)

Selective Serotonin Reuptake Inhibitors — including fluoxetine, sertraline, escitalopram, and fluvoxamine — are the most widely used medications for anxiety disorders, depression, and OCD in children and adolescents.

Common concerns addressed:

  • “Is there a black box warning?” — Yes. The FDA requires a black box warning regarding an increased risk of suicidal ideation (not completed suicide) in youth in the early weeks of SSRI treatment. This risk is real, modest, and manageable with appropriate monitoring — which is exactly what Linden Spital, PMHNP provides.
  • “How long does my child need to stay on medication?” — Duration depends on the condition, the severity, and the clinical response. First episodes of depression or anxiety are typically treated for 6–12 months following remission before a taper is considered. OCD often requires longer treatment.
  • “Are SSRIs addictive?” — No. SSRIs do not produce dependence in the clinical sense. They do require gradual tapering when discontinued.

Mood Stabilizers and Atypical Antipsychotics

Used for bipolar disorder, DMDD, and severe emotional dysregulation — particularly when stimulants and SSRIs have not been sufficient. These medications require more intensive monitoring (metabolic labs, cardiac monitoring in some cases) and are managed carefully at BRN Psychiatry.

Sleep Medications

Melatonin has the strongest evidence base for sleep initiation difficulties in children and adolescents, particularly in autism. Other options may be considered depending on the clinical picture.

Monitoring: What Ongoing Medication Management Looks Like

Prescribing a medication is the beginning, not the end, of psychiatric medication management. At BRN Psychiatry, ongoing monitoring includes:

  • Regular follow-up appointments — more frequent early in treatment, tapering to maintenance frequency as stability is achieved
  • Standardized symptom tracking (rating scales, parent and teacher reports)
  • Weight and vital sign monitoring for stimulant medications
  • Metabolic monitoring as clinically indicated
  • Side effect review and dose adjustment as needed
  • Communication with the child’s pediatrician and therapist throughout

Linden Spital, PMHNP does not prescribe and disappear. Medication management is an ongoing clinical relationship.

What About “Starting with Therapy First”?

For mild-to-moderate conditions, many providers and families prefer to begin with therapy before considering medication — and this is often clinically appropriate. CBT, ERP, and other evidence-based therapies produce durable outcomes for anxiety, depression, and OCD and may be sufficient without medication in many cases.

However, for moderate-to-severe conditions, or when a child’s symptoms are too intense to engage meaningfully with therapy, waiting to “try therapy first” can mean months of unnecessary suffering and academic and social decline that compound the underlying illness.

The decision is always individualized and always collaborative. There is no universal right answer — only the right answer for each specific child.

Helpful Resources

Schedule a Medication Consultation at BRN Psychiatry

Whether you’re considering medication for the first time, seeking a second opinion, or managing an existing prescription that isn’t working — BRN Psychiatry is here to help.

Linden Spital, PMHNP provides comprehensive psychiatric evaluation and collaborative medication management for children and adolescents across the South Shore of Massachusetts: Quincy, Weymouth, Braintree, Hingham, Plymouth, Scituate, Marshfield, Norwell, Duxbury, Milton, and Randolph.

Schedule Appointment with BRN Psychiatry

Linden Spital, PMHNP is a psychiatric mental health nurse practitioner at BRN Psychiatry, providing child and adolescent psychiatric evaluation and medication management on the South Shore of Massachusetts.

This post is for informational purposes only and does not constitute medical advice. Consult a qualified provider for guidance specific to your child.

Similar Posts